Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Intra-breath measures of respiratory mechanics in healthy African infants detect risk of respiratory illness in early life

Intra-breath forced oscillation technique can identify healthy infants at risk of developing LRTI, wheezing or severe illness in the first year of life

Research

Behavior in Children with Fetal Alcohol Spectrum Disorders in Remote Australia: A Population-Based Study

Children with FASD have more teacher-reported behavioral impairment than children without FASD. In remote Australian communities, academic performance is poor.

Research

Prenatal maternal stress events and phenotypic outcomes in Autism Spectrum Disorder

ASD, in the context of prenatal maternal stress exposure, may be associated with a more severe phenotype, particularly when there are multiple prenatal exposures

Research

Identification and characterization of a dendritic cell precursor in parenchymal lung tissue

This is the first study to describe a pulmonary precursor cell for dendritic cells in lung tissue

Research

Investigating the relationship between environmental factors and respiratory health outcomes in school children using the forced oscillation technique

The significance of both indoor and outdoor sources of air pollution and effect modifiers such as green space and heating require further investigation

Research

Extreme heat threatens the health of Australians

Heatwaves have serious health impacts and we need a better approach to prevention and management

Research

Hospital use in Aboriginal and non-Aboriginal patients with chronic disease

Aboriginal people use health services in a different manner when compared to non-Aboriginal people

Research

Family structure and childhood mental disorders: new findings from Australia

This report provides new evidence of the relationships between family structure and childhood mental disorders in an under-researched context, Australia

Research

Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect.

Recurrent severe asthma exacerbations are associated with decreased lung growth or accelerated loss of long function and add substantially to cost and morbidity